Regulatory

Latest News

FDA Clears Positrigo’s NeuroLF Brain PET System for the Diagnosis of Multiple Brain Disorders
FDA Clears Positrigo’s NeuroLF Brain PET System for the Diagnosis of Multiple Brain Disorders

July 17th 2024

Clearance of the NeuroLF Brain PET system marks Positrigo’s first device of its kind to be approved in the United States.

FDA Grants Fast Track Designation to Abdera Therapeutics’ Treatment for Extensive-Stage Small Cell Lung Cancer
FDA Grants Fast Track Designation to Abdera Therapeutics’ Treatment for Extensive-Stage Small Cell Lung Cancer

July 17th 2024

FDA Grants Fast Track Designation to Sumitomo Pharma’s Novel Treatment for Patients with Relapsed or Refractory Acute Myeloid Leukemia
FDA Grants Fast Track Designation to Sumitomo Pharma’s Novel Treatment for Patients with Relapsed or Refractory Acute Myeloid Leukemia

July 15th 2024

FDA Clears Artelo Biosciences’ Investigational New Drug Application for Chemotherapy-Induced Peripheral Neuropathy Treatment
FDA Clears Artelo Biosciences’ Investigational New Drug Application for Chemotherapy-Induced Peripheral Neuropathy Treatment

July 15th 2024

FDA Issues Complete Response Letter to Novo Nordisk for Icodec, a Once-Weekly Basal Insulin for the Treatment of Diabetes Mellitus
FDA Issues Complete Response Letter to Novo Nordisk for Icodec, a Once-Weekly Basal Insulin for the Treatment of Diabetes Mellitus

July 11th 2024

Video Interviews

More News